Muñoz, M. et al. Evaluating the contribution of genetics and familial shared environment to common disease using the UK Biobank. Nat. Genet. 48, 980–983 (2016).
Feinleib, M. et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am. J. Epidemiol. 106, 284–285 (1977).
Poulter, N.R., Prabhakaran, D. & Caulfield, M. Hypertension. Lancet 386, 801–812 (2015).
Mongeau, J.G., Biron, P. & Sing, C.F. The influence of genetics and household environment upon the variability of normal blood pressure: the Montreal Adoption Survey. Clin. Exp. Hypertens. A 8, 653–660 (1986).
Forouzanfar, M.H. et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 2287–2323 (2015).
Sundström, J. et al. Blood pressure–lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 384, 591–598 (2014).
Cabrera, C.P. et al. Exploring hypertension genome-wide association studies findings and impact on pathophysiology, pathways, and pharmacogenetics. Wiley Interdiscip. Rev. Syst. Biol. Med. 7, 73–90 (2015).
Ehret, G.B. et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat. Genet. 48, 1171–1184 (2016).
Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151–1161 (2016).
Liu, C. et al. Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Nat. Genet. 48, 1162–1170 (2016).
Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282–1293 (2015).
Elliott, P. & Peakman, T.C. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int. J. Epidemiol. 37, 234–244 (2008).
Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
Huang, J. et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat. Commun. 6, 8111 (2015).
Hoffmann, T.J. et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat. Genet. 49, 54–64 (2017).
Staley, J.R. et al. PhenoScanner: a database of human genotype–phenotype associations. Bioinformatics 32, 3207–3209 (2016).
Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387, 957–967 (2016).
Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 43, 531–538 (2011).
Munroe, P.B., Barnes, M.R. & Caulfield, M.J. Advances in blood pressure genomics. Circ. Res. 112, 1365–1379 (2013).
den Hoed, M. et al. Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45, 621–631 (2013).
Hamilton, C.A., Brosnan, M.J., McIntyre, M., Graham, D. & Dominiczak, A.F. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37, 529–534 (2001).
Shin, S.Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543–550 (2014).
Raffler, J. et al. Genome-wide association study with targeted and non-targeted NMR metabolomics identifies 15 novel loci of urinary human metabolic individuality. PLoS Genet. 11, e1005487 (2015).
van Setten, J. et al. Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis 228, 400–405 (2013).
McCarthy, J.J. et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J. Med. Genet. 41, 334–341 (2004).
van Meurs, J.B. et al. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am. J. Clin. Nutr. 98, 668–676 (2013).
Pu, X. et al. ADAMTS7 cleavage and vascular smooth muscle cell migration is affected by a coronary-artery-disease-associated variant. Am. J. Hum. Genet. 92, 366–374 (2013).
Rizzoni, D. & Agabiti-Rosei, E. Structural abnormalities of small resistance arteries in essential hypertension. Intern. Emerg. Med. 7, 205–212 (2012).
Ray, R. et al. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 31, 1368–1376 (2011).
Touyz, R.M. & Montezano, A.C. Vascular Nox4: a multifarious NADPH oxidase. Circ. Res. 110, 1159–1161 (2012).
Steppan, J., Barodka, V., Berkowitz, D.E. & Nyhan, D. Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol. Res. Pract. 2011, 263585 (2011).
Yan, F. et al. Nox4 and redox signaling mediate TGF-β-induced endothelial cell apoptosis and phenotypic switch. Cell Death Dis. 5, e1010 (2014).
Chan, E.C. et al. Nox4 modulates collagen production stimulated by transforming growth factor β1 in vivo and in vitro. Biochem. Biophys. Res. Commun. 430, 918–925 (2013).
Vasa-Nicotera, M. et al. miR-146a is modulated in human endothelial cell with aging. Atherosclerosis 217, 326–330 (2011).
Tian, X. et al. Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling. PLoS One 6, e18136 (2011).
Takimoto, E. et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat. Med. 11, 214–222 (2005).
Pérez, N.G. et al. Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction. Hypertension 49, 1095–1103 (2007).
Oliver, J.J., Melville, V.P. & Webb, D.J. Effect of regular phosphodiesterase type 5 inhibition in hypertension. Hypertension 48, 622–627 (2006).
Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009).
Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41, 666–676 (2009).
DeStefano, A.L. et al. Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18q. Am. J. Hum. Genet. 63, 1425–1430 (1998).
Hong, X. et al. Genetic polymorphisms of the urea transporter gene are associated with antihypertensive response to nifedipine GITS. Methods Find. Exp. Clin. Pharmacol. 29, 3–10 (2007).
Takimoto, E. et al. Sodium calcium exchanger plays a key role in alteration of cardiac function in response to pressure overload. FASEB J. 16, 373–378 (2002).
Ronaldson, P.T. & Davis, T.P. Targeting transporters: promoting blood–brain barrier repair in response to oxidative stress injury. Brain Res. 1623, 39–52 (2015).
Carta, L. et al. Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J. Biol. Chem. 281, 8016–8023 (2006).
Kazenwadel, J. et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 119, 1283–1291 (2012).
Akashi, M., Higashi, T., Masuda, S., Komori, T. & Furuse, M. A coronary artery disease–associated gene product, JCAD/KIAA1462, is a novel component of endothelial cell–cell junctions. Biochem. Biophys. Res. Commun. 413, 224–229 (2011).
Cakstina, I. et al. Primary culture of avian embryonic heart forming region cells to study the regulation of vertebrate early heart morphogenesis by vitamin A. BMC Dev. Biol. 14, 10 (2014).
Wang, J., Karra, R., Dickson, A.L. & Poss, K.D. Fibronectin is deposited by injury-activated epicardial cells and is necessary for zebrafish heart regeneration. Dev. Biol. 382, 427–435 (2013).
Dietrich, T. et al. ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions. Basic Res. Cardiol. 102, 298–307 (2007).
Stoynev, N. et al. Gene expression in peripheral blood of patients with hypertension and patients with type 2 diabetes. J. Cardiovasc. Med. (Hagerstown) 15, 702–709 (2014).
Erdos, B., Backes, I., McCowan, M.L., Hayward, L.F. & Scheuer, D.A. Brain-derived neurotrophic factor modulates angiotensin signaling in the hypothalamus to increase blood pressure in rats. Am. J. Physiol. Heart Circ. Physiol. 308, H612–H622 (2015).
Chan, S.H., Wu, C.W., Chang, A.Y., Hsu, K.S. & Chan, J.Y. Transcriptional upregulation of brain-derived neurotrophic factor in rostral ventrolateral medulla by angiotensin II: significance in superoxide homeostasis and neural regulation of arterial pressure. Circ. Res. 107, 1127–1139 (2010).
Crespo, K., Ménard, A. & Deng, A.Y. Retinoblastoma-associated protein 140 as a candidate for a novel etiological gene to hypertension. Clin. Exp. Hypertens. 38, 533–540 (2016).
Watanabe, Y. et al. Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study. Hypertens. Res. 33, 129–134 (2010).
Gale, D.P., Harten, S.K., Reid, C.D., Tuddenham, E.G. & Maxwell, P.H. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2α mutation. Blood 112, 919–921 (2008).
Yndestad, A. et al. Elevated levels of activin A in clinical and experimental pulmonary hypertension. J. Appl. Physiol. 106, 1356–1364 (2009).
Sacks, F.M. et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med. 344, 3–10 (2001).
Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br. Med. J. 297, 319–328 (1988).
Whelton, P.K. et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. J. Am. Med. Assoc. 288, 1882–1888 (2002).
Chan, Q. et al. An update on nutrients and blood pressure. J. Atheroscler. Thromb. 23, 276–289 (2016).
Khera, A.V. et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N. Engl. J. Med. 375, 2349–2358 (2016).
Wain, L.V. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir. Med. 3, 769–781 (2015).
Tobin, M.D., Sheehan, N.A., Scurrah, K.J. & Burton, P.R. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat. Med. 24, 2911–2935 (2005).
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
Barnes, M.R. Exploring the landscape of the genome. Methods Mol. Biol. 628, 21–38 (2010).
Gong, J. et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum. Mutat. 33, 254–263 (2012).
Pers, T.H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
Dunham, I., Kulesha, E., Iotchkova, V., Morganella, S. & Birney, E. FORGE: a tool to discover cell specific enrichments of GWAS associated SNPs in regulatory regions. F1000Res. 4, 18 (2015).
Dozmorov, M.G., Cara, L.R., Giles, C.B. & Wren, J.D. GenomeRunner: automating genome exploration. Bioinformatics 28, 419–420 (2012).
McLean, C.Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495–501 (2010).
Elliott, P. et al. The Airwave Health Monitoring Study of police officers and staff in Great Britain: rationale, design and methods. Environ. Res. 134, 280–285 (2014).
Petersen, M. et al. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance–based partial least-squares regression models. Clin. Chem. 51, 1457–1461 (2005).
Chadeau-Hyam, M. et al. Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. J. Proteome Res. 9, 4620–4627 (2010).